Helmy Eltoukhy, Co-Chief Executive Officer at Guardant Health, Inc. (GH), sold 100,000 shares at $125.57 ($12.6M) on 2026-06-05, disclosed to the SEC on 2026-06-08.
Open-market sale of $12.6M GH by Co-Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.57 | 49,716 | $6.2M | 49.4% |
| 2 | $126.33 | 33,843 | $4.3M | 33.9% |
| 3 | $127.02 | 1,100 | $140K | 1.1% |
| 4 | $128.25 | 13,787 | $1.8M | 14.0% |
| 5 | $130.21 | 554 | $72K | 0.6% |
| 6 | $131.78 | 900 |
| $119K |
| 0.9% |
| 7 | $132.55 | 100 | $13K | 0.1% |
| Total | $126.30 avg | 100,000 | $12.6M | 100% |
| Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |
| GH | SELL | 2021-04-26 | $2.6M | — | Filing → |